Provided by Tiger Trade Technology Pte. Ltd.

Quince Therapeutics, Inc.

33.93
+1.825.67%
Post-market: 33.930.00000.00%19:30 EDT
Volume:10K
Turnover:317.02K
Market Cap:34.51M
PE:-0.37
High:34.09
Open:32.77
Low:32.57
Close:32.11
52wk High:909.98
52wk Low:15.10
Shares:1.02M
Float Shares:860.30K
Volume Ratio:0.34
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-90.9250
EPS(LYR):-335.2669
ROE:-153.84%
ROA:-31.51%
PB:-0.98
PE(LYR):-0.10

Loading ...

Quince Therapeutics announces LAM-001 data

TIPRANKS
·
May 18

Quince Therapeutics acquires Orphai Therapeutics, terms undisclosed

TIPRANKS
·
May 18

Quince Therapeutics prices private placement raising up to $187 million

Reuters
·
May 18

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM

Reuters
·
May 18

Quince Therapeutics acquires Orphai Therapeutics, adds inhaled rapamycin program LAM-001

Reuters
·
May 18

Quince Announces Acquisition of Orphai and up to $187 Million Private Placement to Advance Pulmonary Pipeline

THOMSON REUTERS
·
May 18

Quince Therapeutics reports Phase 2a LAM-001 gains in PH-ILD patients

Reuters
·
May 18

Quince Therapeutics - Lam-001 Generally Well Tolerated in Phase 2a Study

THOMSON REUTERS
·
May 18

Quince Therapeutics - Lam-001 Phase 2a in Ph-Ild Shows 67.4M 6Mwd Improvement, 33.9% Pvr Reduction at 24 Weeks

THOMSON REUTERS
·
May 18

Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in Pah and Ph-Ild

THOMSON REUTERS
·
May 18

Quince Therapeutics - Phase 2B Trial in Ph-Ild to Start Mid-2026, Topline Data Expected Q1 2028

THOMSON REUTERS
·
May 18

Quince Therapeutics swings to Q1 net income of $35.91 million; operating loss narrows 2% to $14.59 million

Reuters
·
May 12

Quince Therapeutics Inc expected to post a loss of $2.56 a share - Earnings Preview

Reuters
·
May 08

Quince Therapeutics regains Nasdaq $1 minimum bid price compliance

Reuters
·
Apr 29

Quince Therapeutics appoints June Bray to board as independent director

Reuters
·
Apr 23

Largest borrow rate increases among liquid names

TIPRANKS
·
Apr 21

Quince Therapeutics announces annual shareholder meeting via webcast

Reuters
·
Apr 18

NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM

Reuters
·
Apr 12

Quince Therapeutics trading halted, news pending

TIPRANKS
·
Apr 11

Quince Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Apr 11